Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01589341 · ClinicalTrials.gov registry record
Studying Chromosomes in Samples From Younger Patients With Neuroblastoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 300
- Enrollment target
NCT01589341: Completed study, sponsored by Children's Oncology Group.
NCT01589341 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01589341 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This research studies chromosomes in samples from younger patients with neuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
Primary Outcome
Estimated by the Kaplan-Meier method.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2012-04 |
What the finished NCT01589341 record still lists
NCT01589341 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01589341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01589341 about?
NCT01589341 is a clinical study titled "Studying Chromosomes in Samples From Younger Patients With Neuroblastoma". This research studies chromosomes in samples from younger patients with neuroblastoma. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
What is the current status of trial NCT01589341?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2012-04.
What interventions are being tested in trial NCT01589341?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01589341?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia